Paul-Ehrlich-Institut

Regulation Category Type · Breadth Date

Regeneron recalls one batch of Libtayo (Cemiplimab) 350 mg due to a sealing defect in the vial.

Paul-Ehrlich-Institut · Germany

Pharmaceuticals Pharmacovigilance

Safety alert & recall Product class Jul 29, 2026

Showing 1 of 1 tracked update Health-tech only